Viroment

Viroment

Early Stage

Our high-tech facilities are changing the face of protein production!

Our high-tech facilities are changing the face of protein production!

Overview

Raised to Date: Raised: $1,070,000

Total Commitments ($USD)

Platform

Wefunder

Start Date

12/17/2020

Close Date

03/23/2021

Min. Goal
$50,000
Max. Goal
$600,000
Min. Investment

$100

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$13,500,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

03/30/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$11,263

# of Investors

620

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2020

Industry

Farming & Agriculture

Tech Sector

Non-Tech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Minneapolis, Minnesota

Business Type

Life Style

Viroment Equity, a builder of high-tech agricultural facilities, is raising funds on Wefunder. The company builds and leases technologically advanced agricultural facilities to the world’s top pork producers. The barns made by Viroment are fitted with odor-eliminating manure filtration technology, which also creates high-value dry fertilizer in the process. Viroment was founded by Paul Koenig in October 2020. The funds from the current crowdfunding campaign, with a minimum target of $50,000 and a maximum target of $600,000, will be used towards legal and accounting expenses, marketing and advertising, land acquisition, preconstruction costs, and equipment. Viroment is creating high-tech barns of the future at lower costs, less regulation, and high sustainability.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$25,000

$0

Accounts Receivable

$0

$0

Total Assets

$25,000

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 12/17/2020
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Viroment 03/22/2021 Wefunder $13,500,000 $1,070,000 Equity - Preferred Funded RegCF
Viroment 10/30/2020 Wefunder - $439,975 Debt Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Viroment Equity on Wefunder
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $13,500,000
Price per Share: $1.00

Follow company

Follow Viroment Equity on Wefunder

Buy Viroment's Deal Report

Warning: according to the close date for this deal, Viroment may no longer be accepting investments.

Viroment Deal Report

Get KingsCrowd’s comprehensive report on Viroment including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Viroment is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Viroment deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge